Abstract
The purpose of this study was to evaluate and compare the potential of using various biomaterials as a carrier of rhBMP-2 in the subcutaneous layer of rats. 5 subcutaneous defects were made in each of the dorsal surfaces of 10 rats. Then, the rats were divided into the following groups: Control group: sham-surgery control, Experimental group 1: rhBMP-2/Bio-Oss®, Experimental group 2: rhBMP-2/Collatape®, Experimental group 3: rhBMP-2/nCS. Histological and histometrical analysis were performed after the rats were sacrificed at 2 and 4 weeks. Regardless of the type of carrier, the groups treated with rhBMP-2 showed significantly greater bone formation when compared to the control group. The amount of new bone formation was greater at 4 week than 2 week. Total bone formation (%) at 4 week was the greatest in rhBMP/Bio-Oss® (26.76±10.13) group, followed by rhBMP/Collatape® (20.38±5.27) and rhBMP/nCS (4.34±2.58). Within the limitation of this study, the results showed that Bio-Oss®, Collatape®, nanocalcium sulfate all showed new bone formation when used as a carrier of rhBMP-2 in the subcutaneous layer of rats, indicating potential use as carriers for rhBMP-2.
Similar content being viewed by others
References
Lindholm TC, Lindholm TS, Marttinen A, Urist MRR. Bovine bone morphogenetic protein (bBMP/NCP)-induced repair of skull trephine defects in pigs. Clin Orthop Relat Res 1994;301:263–270.
Urist MR, Strates BS, Bone morphogenetic protein. J Dent Res 1971;50: 1392–1406.
Bae MS, Kim DW, Kim SE Choi KK, Kwon IKK. BMP-2 immobilized gelatin-ß-chitosan scaffold for bone regeneration. Tissue Eng Regen Med 2009;6:609–614.
Wikesjö UM, Guglielmoni P, Promsudthi A, Cho KS, Trombelli L, Selvig KA, et al. Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 1999;26:392–400.
Kenley R, Marden L, Turek T, Jin L, Ron E, Hollinger JOO. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res 1994;28:1139–1147.
Gao TJ, Lindholm TS, Kommonen B, Ragni P, Paronzini A, Lindholm TC, et al. Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen. J Biomed Mater Res 1996; 32:505–512.
Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JOO. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 1997;79:1778–1790.
Nevins M, Kirker-Head C, Nevins M, Wozney JA, Palmer R, Graham D. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2. Int J Periodontics Restorative Dent 1996;16:8–19.
Zheng LW, Wong MC, Rabie AB, Cheung LKK. Evaluation of recombinant human bone morphogenetic protein-2 in mandibular distraction osteogenesis in rabbits: effect of dosage and number of doses on formation of bone. Br J Oral Maxillofac Surg 2006;44:487–494.
Yamazaki Y, Oida S, Akimoto Y, Shioda S. Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris. Clin Orthop Relat Res 1998;234:240–249.
Choi SH, Kim CK, Cho KS, Huh JS, Sorensen RG, Wozney JM, et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63–72.
Kawamura M, Urist MRR. Human fibrin is a physiologic delivery system for bone morphogenetic protein. Clin Orthop Relat Res 1988;235:302–310.
Hämmerle CH, Olah AJ, Schmid J, Flückiger L, Gogolewski S, Winkler JR, et al., The biological effect of natural bone mineral on bone neoformation on the rabbit skull. Clin Oral Implants Res 1997;8:198–207.
Slotte C, Lundgren D. Augmentation of calvarial tissue using non-permeable silicone domes and bovine bone mineral. An experimental study in the rat. Clin Oral Implants Res 1999;10:468–476.
Bell WHH. Resorption characteristics of bone and bone substitutes. Oral Surg Oral Med Oral Pathol 1964;17:650–657.
Stevens MM, George JHH. Exploring and engineering the cell surface interface. Science 2005;310: 1135–1138.
Park YB, Mohan K, Al-Sanousi A, Almaghrabi B, Genco RJ, Swihart MT, et al. Synthesis and characterization of nanocrystalline calcium sulfate for use in osseous regeneration. Biomed Mater 2011;6:055007.
Jung JH, Yun JH, Um YJ, Jung UW, Kim CS, Choi SH, et al. Bone formation of Escherichia coli expressed rhBMP-2 on absorbable collagen block in rat calvarial defects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:298–305.
Choi H, Park NJ, Jamiyandorj O, Choi KH, Hong MH, Oh S, et al. Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed recombinant human bone morphogenetic protein-2. J Periodontal Implant Sci 2012;42: 119–126.
Hyun SJ, Han DK, Choi SH, Chai JK, Cho KS, Kim CK, et al. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects. J Periodontol 2005; 76:1667–1674.
Jung UW, Choi SY, Pang EK, Kim CS, Choi SH, Cho KSS. The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2006;77:765–772.
Kuboki Y, Saito T, Murata M, Takita H, Mizuno M, Inoue M, et al. Two distinctive BMP-carriers induce zonal chondrogenesis and membranous ossification, respectively; geometrical factors of matrices for cell-differentiation. Connect Tissue Res 1995;32:219–226.
Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 2011;17:1389–1399.
Barboza EP, Duarte ME, Geolás L, Sorensen RG, Riedel GE, Wikesjö UM. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000;71:488–496.
Fucini SE, Quintero G, Gher ME, Black BS, Richardson ACC. Small versus large particles of demineralized freeze-dried bone allografts in human intrabony periodontal defects. J Periodontol 1993;64:844–847.
Okubo Y1, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, Tani Y, et al. Comparative study of intramuscular and intraskeletal osteogenesis by recombinant human bone morphogenetic protein-2. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:34–38.
Yoshida K, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, Tani Y, et al. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. J Craniomaxillofac Surg 1998;26:112–115.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Sunkyu Lee and Hyunmin Choi equally contributed to the works described in this manuscript.
Rights and permissions
About this article
Cite this article
Lee, S., Choi, H., Shim, JS. et al. Comparative study of recombinant human bone morphogenetic protein-2 carriers in rat subcutaneous tissues: Pilot study. Tissue Eng Regen Med 12 (Suppl 2), 138–146 (2015). https://doi.org/10.1007/s13770-015-0437-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-015-0437-0